These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 34319442
1. Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease. Chen CD, Joseph-Mathurin N, Sinha N, Zhou A, Li Y, Friedrichsen K, McCullough A, Franklin EE, Hornbeck R, Gordon B, Sharma V, Cruchaga C, Goate A, Karch C, McDade E, Xiong C, Bateman RJ, Ghetti B, Ringman JM, Chhatwal J, Masters CL, McLean C, Lashley T, Su Y, Koeppe R, Jack C, Klunk WE, Morris JC, Perrin RJ, Cairns NJ, Benzinger TLS. Acta Neuropathol; 2021 Oct; 142(4):689-706. PubMed ID: 34319442 [Abstract] [Full Text] [Related]
3. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, Lopresti BJ, Ziolko S, Bi W, Paljug WR, Debnath ML, Hope CE, Isanski BA, Hamilton RL, DeKosky ST. Brain; 2008 Jun; 131(Pt 6):1630-45. PubMed ID: 18339640 [Abstract] [Full Text] [Related]
4. Correspondence between in vivo (11)C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques. Driscoll I, Troncoso JC, Rudow G, Sojkova J, Pletnikova O, Zhou Y, Kraut MA, Ferrucci L, Mathis CA, Klunk WE, O'Brien RJ, Davatzikos C, Wong DF, Resnick SM. Acta Neuropathol; 2012 Dec; 124(6):823-31. PubMed ID: 22864813 [Abstract] [Full Text] [Related]
5. 11C-PiB PET can underestimate brain amyloid-β burden when cotton wool plaques are numerous. Abrahamson EE, Kofler JK, Becker CR, Price JC, Newell KL, Ghetti B, Murrell JR, McLean CA, Lopez OL, Mathis CA, Klunk WE, Villemagne VL, Ikonomovic MD. Brain; 2022 Jun 30; 145(6):2161-2176. PubMed ID: 34918018 [Abstract] [Full Text] [Related]
6. Imaging of amyloid deposition in human brain using positron emission tomography and [18F]FACT: comparison with [11C]PIB. Ito H, Shinotoh H, Shimada H, Miyoshi M, Yanai K, Okamura N, Takano H, Takahashi H, Arakawa R, Kodaka F, Ono M, Eguchi Y, Higuchi M, Fukumura T, Suhara T. Eur J Nucl Med Mol Imaging; 2014 Apr 30; 41(4):745-54. PubMed ID: 24233004 [Abstract] [Full Text] [Related]
7. PET evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer's disease-causing Presenilin-1 E280A mutation carriers. Ghisays V, Lopera F, Goradia DD, Protas HD, Malek-Ahmadi MH, Chen Y, Devadas V, Luo J, Lee W, Baena A, Bocanegra Y, Guzmán-Vélez E, Pardilla-Delgado E, Vila-Castelar C, Fox-Fuller JT, Hu N, Clayton D, Thomas RG, Alvarez S, Espinosa A, Acosta-Baena N, Giraldo MM, Rios-Romenets S, Langbaum JB, Chen K, Su Y, Tariot PN, Quiroz YT, Reiman EM, API ADAD Colombia Trial Group. Neuroimage Clin; 2021 Apr 30; 31():102749. PubMed ID: 34252876 [Abstract] [Full Text] [Related]
8. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B. Leinonen V, Alafuzoff I, Aalto S, Suotunen T, Savolainen S, Någren K, Tapiola T, Pirttilä T, Rinne J, Jääskeläinen JE, Soininen H, Rinne JO. Arch Neurol; 2008 Oct 30; 65(10):1304-9. PubMed ID: 18695050 [Abstract] [Full Text] [Related]
9. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG. Shin J, Lee SY, Kim SJ, Kim SH, Cho SJ, Kim YB. Neuroimage; 2010 Aug 15; 52(2):488-96. PubMed ID: 20385246 [Abstract] [Full Text] [Related]
10. Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-β PET Signal. McCarter SJ, Lesnick TG, Lowe V, Mielke MM, Constantopoulos E, Rabinstein AA, Przybelski SA, Botha H, Jones DT, Ramanan VK, Jack CR, Petersen RC, Knopman D, Boeve BF, Murray ME, Dickson DW, Vemuri P, Kantarci K, Reichard RR, Graff-Radford J. Neurology; 2021 Nov 02; 97(18):e1799-e1808. PubMed ID: 34504022 [Abstract] [Full Text] [Related]
11. Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study. Ikonomovic MD, Abrahamson EE, Price JC, Hamilton RL, Mathis CA, Paljug WR, Debnath ML, Cohen AD, Mizukami K, DeKosky ST, Lopez OL, Klunk WE. Acta Neuropathol; 2012 Mar 02; 123(3):433-47. PubMed ID: 22271153 [Abstract] [Full Text] [Related]
12. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology. Laforce R, Tosun D, Ghosh P, Lehmann M, Madison CM, Weiner MW, Miller BL, Jagust WJ, Rabinovici GD. Neuroimage Clin; 2014 Mar 02; 4():508-16. PubMed ID: 24818077 [Abstract] [Full Text] [Related]
13. Diagnostic Accuracy of Amyloid versus 18 F-Fluorodeoxyglucose Positron Emission Tomography in Autopsy-Confirmed Dementia. Lesman-Segev OH, La Joie R, Iaccarino L, Lobach I, Rosen HJ, Seo SW, Janabi M, Baker SL, Edwards L, Pham J, Olichney J, Boxer A, Huang E, Gorno-Tempini M, DeCarli C, Hepker M, Hwang JL, Miller BL, Spina S, Grinberg LT, Seeley WW, Jagust WJ, Rabinovici GD. Ann Neurol; 2021 Feb 02; 89(2):389-401. PubMed ID: 33219525 [Abstract] [Full Text] [Related]
14. The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease. Twohig D, Rodriguez-Vieitez E, Sando SB, Berge G, Lauridsen C, Møller I, Grøntvedt GR, Bråthen G, Patra K, Bu G, Benzinger TLS, Karch CM, Fagan A, Morris JC, Bateman RJ, Nordberg A, White LR, Nielsen HM, Dominantly Inherited Alzheimer Network (DIAN). Acta Neuropathol Commun; 2018 Nov 26; 6(1):130. PubMed ID: 30477568 [Abstract] [Full Text] [Related]
15. Amyloid imaging of dutch-type hereditary cerebral amyloid angiopathy carriers. Schultz AP, Kloet RW, Sohrabi HR, van der Weerd L, van Rooden S, Wermer MJH, Moursel LG, Yaqub M, van Berckel BNM, Chatterjee P, Gardener SL, Taddei K, Fagan AM, Benzinger TL, Morris JC, Sperling R, Johnson K, Bateman RJ, Dominantly Inherited Alzheimer Network, Gurol ME, van Buchem MA, Martins R, Chhatwal JP, Greenberg SM. Ann Neurol; 2019 Oct 26; 86(4):616-625. PubMed ID: 31361916 [Abstract] [Full Text] [Related]
16. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, Hotton G, Cutler D, Fox N, Kennedy A, Rossor M, Brooks DJ. Neurology; 2007 Feb 13; 68(7):501-8. PubMed ID: 17065593 [Abstract] [Full Text] [Related]
17. Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection. Ikonomovic MD, Buckley CJ, Heurling K, Sherwin P, Jones PA, Zanette M, Mathis CA, Klunk WE, Chakrabarty A, Ironside J, Ismail A, Smith C, Thal DR, Beach TG, Farrar G, Smith AP. Acta Neuropathol Commun; 2016 Dec 12; 4(1):130. PubMed ID: 27955679 [Abstract] [Full Text] [Related]
18. Plasma acetylcholinesterase activity correlates with intracerebral β-amyloid load. Alkalay A, Rabinovici GD, Zimmerman G, Agarwal N, Kaufer D, Miller BL, Jagust WJ, Soreq H. Curr Alzheimer Res; 2013 Jan 12; 10(1):48-56. PubMed ID: 23157337 [Abstract] [Full Text] [Related]
19. Antibody engagement with amyloid-beta does not inhibit [11C]PiB binding for PET imaging. Xiong M, Dahlén A, Roshanbin S, Wik E, Aguilar X, Eriksson J, Sehlin D, Syvänen S. J Neurochem; 2024 Sep 12; 168(9):2601-2610. PubMed ID: 38721627 [Abstract] [Full Text] [Related]
20. Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease. Shin J, Lee SY, Kim SH, Kim YB, Cho SJ. Neuroimage; 2008 Nov 01; 43(2):236-44. PubMed ID: 18694837 [Abstract] [Full Text] [Related] Page: [Next] [New Search]